Bioaesthetics and regenerative medicine

The document from 2009 discusses the potential of bioaesthetics, which are cosmetic therapies that aim to improve appearance, to become part of mainstream healthcare due to the desire for increased health and longevity. It references a study by Jizeng Qiao et al. from Intercytex on cell therapy for hair loss and a review by George Huang on tooth pulp and dentin regeneration, highlighting the importance of safety and efficacy in these therapies. The paper notes the significant market potential, with companies like L'Oreal investing in aesthetic regenerative medicine, driven by an aging population and economic factors. It suggests that the lessons learned from bioaesthetic therapies could benefit regenerative medicine overall and concludes that these therapies are a valuable addition to the field as long as they focus on regenerating human cells, tissues, or organs to restore normal function.